Axxcess Wealth Management LLC increased its position in shares of CorVel Co. (NASDAQ:CRVL – Free Report) by 211.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,433 shares of the business services provider’s stock after acquiring an additional 1,651 shares during the quarter. Axxcess Wealth Management LLC’s holdings in CorVel were worth $271,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of CRVL. Fifth Third Bancorp boosted its position in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock valued at $36,000 after acquiring an additional 101 shares during the last quarter. Jones Financial Companies Lllp acquired a new position in shares of CorVel during the 4th quarter valued at about $37,000. US Bancorp DE boosted its position in shares of CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 266 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of CorVel by 175.2% during the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock valued at $48,000 after acquiring an additional 275 shares during the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in shares of CorVel by 216.7% during the 4th quarter. Exchange Traded Concepts LLC now owns 532 shares of the business services provider’s stock valued at $59,000 after acquiring an additional 364 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a research report on Thursday, March 13th.
Insider Buying and Selling at CorVel
In other news, Director Steven J. Hamerslag sold 10,000 shares of the stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the sale, the director now owns 314,000 shares of the company’s stock, valued at approximately $38,772,720. This represents a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brandon O’brien sold 1,523 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the sale, the chief financial officer now directly owns 17,142 shares in the company, valued at $2,049,497.52. This represents a 8.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,200 shares of company stock valued at $3,824,115 over the last 90 days. 47.57% of the stock is owned by insiders.
CorVel Price Performance
NASDAQ CRVL opened at $107.86 on Friday. The firm’s 50-day moving average is $112.06 and its two-hundred day moving average is $114.20. CorVel Co. has a 12 month low of $76.20 and a 12 month high of $128.61. The stock has a market capitalization of $5.54 billion, a P/E ratio of 63.45 and a beta of 1.06.
CorVel (NASDAQ:CRVL – Get Free Report) last posted its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.
CorVel Company Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- Stock Dividend Cuts Happen Are You Ready?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Industrial Products Stocks Investing
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Using the MarketBeat Dividend Tax Calculator
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.